Immune Responses to C trachomatis Infections in a Non-Human Primate Model

Infectious Diseases in Obstetrics and Gynecology

Volumn 4, Issue 3, 1996, Pages 159-162

  Patton, Dorothy L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

animal model; cervicitis; Chlamydia trachomatis; cytokines; salpingitis

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL INCLUSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; IMMUNE RESPONSE; INFLAMMATION; MACACA; NONHUMAN; PELVIC INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALPINGITIS; SCAR FORMATION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS;

EID: 0029801393     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/S1064744996000348     Document Type: Article

References (14)

1. Centers for Disease Control. 1990 Division of STD/HIV prevention annual report. U.S. Department of Health and Human Services, Public Health Service, 1990.
2. Quinn TC, Cates W Jr.: The epidemiology of sexually transmitted diseases, 1990. In: Quinn TC, Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Vol 8: Immunopathogenesis of Sexually Transmitted Diseases. New York: Raven Press, 1991.
3. Washington AE, Johnson RE, Sanders LL, et al.: Incidence of Chlamydia trachomatis infections in the United States: Using reported Neisseria gonorrhoeae as a surrogate. In: Oriel D, Ridgeway G, Schachter J, et al. (eds): Chlamydia Infections. Cambridge, England: Cambridge University Press, 1986;487.
4. Washington AE, Johnson RE, Sanders LL: Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 257: 2070–2072, 1987.
5. Wolner-Hanssen P, Patton DL, Holmes KK: Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex Trans Dis 18: 21–25, 1991.
6. Patton DL, Wolner-Hanssen P, Cosgrove SJ, Thompson JL, Holmes KK: Acute salpingitis in a pig-tailed macaque induced by cervical inoculations of Chlamydia trachomatis. Abstr. No. 20. Presented at Infectious Disease Society of Obstetrics and Gynecology, Seattle WA, August 7–11, 1990.
7. Patton DL, Wolner-Hanssen P, Holmes KK: The effects of Chlamydia trachomatis on the female reproductive tract of the Macaca nemestrina after a single tubal challenge following repeated cervical inoculations. Obstet Gynecol 76: 643–650, 1990.
8. Van Voorhis WC, Barrett LK, Cosgrove Sweeney YT, Kuo CC, Patton DL: Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J Infect Dis 174: 647–50, 1996.
9. 2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immun 7: 145–73, 1989.
10. Shaw RJ, Benedict SH, Clark RAF, King Jr, TE: Pathogenesis of pulmonary fibrosis in interstitial lung disease: Alveolar macrophage PDGF(ß) gene activation and up-regulation by interferon gamma. Am Rev Resp Dis 143: 167–173, 1991.
11. Border WA, Ruoslahti E: Transforming growth factorbeta in disease: The dark side of tissue repair. J Clin Invest 90: 1–7, 1992.
12. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-ß protects against protects against the scarring in experimental kidney disease. Nature 360: 361–364, 1992.
13. Brakenhoff PJ. De Groot ER, Evers RF, Pannekoek H, Aarden LA: Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 139: 4116–21, 1987.
14. 2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150: 353–360, 1993.